Cargando…
Comparable prognosis in different neonatal histidine-tryptophan-ketoglutarate dosage management
BACKGROUND: Histidine-tryptophan-ketoglutarate (HTK) is a solution commonly used for organ transplantation. However, there is no certified fixed regimen for on-pump heart surgery in neonates. We aimed to retrospectively evaluate the outcomes related to different HTK dosages and to analyze the safety...
Autores principales: | Bai, Li-Ting, Tong, Yuan-Yuan, Liu, Jin-Ping, Feng, Zheng-Yi, Zhao, Ju, Guo, Sheng-Wen, Jin, Yu, Zhang, Pei-Yao, Li, Yi-Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710314/ https://www.ncbi.nlm.nih.gov/pubmed/34711715 http://dx.doi.org/10.1097/CM9.0000000000001643 |
Ejemplares similares
-
Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate – a retrospective study
por: Lindner, Gregor, et al.
Publicado: (2012) -
In Vivo Neuroprotective Effect of Histidine-Tryptophan-Ketoglutarate Solution in an Ischemia/Reperfusion Spinal Cord Injury Animal Model
por: Kang, Shin Kwang, et al.
Publicado: (2016) -
HTK-N: Modified Histidine-Tryptophan-Ketoglutarate Solution—A Promising New Tool in Solid Organ Preservation
por: Mohr, Annika, et al.
Publicado: (2020) -
Histidine–tryptophan–ketoglutarate solution versus multidose cardioplegia for myocardial protection in cardiac surgeries: a systematic review and meta-analysis
por: Albadrani, Muayad
Publicado: (2022) -
Comparative study between fructose 1-6 bisphosphate and histidine-tryptophan-ketoglutarate in liver preservation in rats submitted to total cold ischemia
por: Smecellato, Fernanda Bombonato, et al.
Publicado: (2020)